Clinical Trial

Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.

Study acronym: PERISCOPEII
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2025 (before its estimated September 17, 2025 completion). Its status may not reflect the trial's current state.
Summary
A randomized controlled two-armed phase III trial for gastric cancer patients with peritoneal dissemination. Randomization between gastrectomy + cytoreductive surgery + HIPEC (experimental arm) and palliative systemic chemotherapy (standard arm).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2017-11-15; most recent amendment 2025-07-16.
Status change: Recruiting → Active, Not Recruiting 2025-07-16
Trial Details
NCT Number NCT03348150
Lead Sponsor The Netherlands Cancer Institute
Collaborators: Erasmus Medical Center, UMC Utrecht, University Medical Center Groningen, Catharina Ziekenhuis Eindhoven
Conditions Stomach Neoplasm, Peritoneal Carcinomatosis
Enrollment 102 participants
Start Date 2017-10-01
Primary Completion 2025-09-17 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-17